Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)

Masashi Niwakawa; Katsuyoshi Hashine; Raizo Yamaguchi; Hirofumi Fujii; Yasuo Hamamoto; Koichi Fukino; Takahiko Tanigawa; Yoshiteru Sumiyoshi

doi:10.1007/s10637-011-9771-9

Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)

Masashi Niwakawa
, Katsuyoshi Hashine
, Raizo Yamaguchi
, Hirofumi Fujii
, Yasuo Hamamoto
, Koichi Fukino
, Takahiko Tanigawa
, Yoshiteru Sumiyoshi

研究成果: Comment/debate › 査読

本文言語	English
ページ（範囲）	1274-1275
ページ数	2
ジャーナル	Investigational new drugs
巻	30
号	3
DOI	https://doi.org/10.1007/s10637-011-9771-9
出版ステータス	Published - 2012 6月
外部発表	はい

ASJC Scopus subject areas

腫瘍学
薬理学
薬理学（医学）

文献へのアクセス

10.1007/s10637-011-9771-9

他のファイルとリンク

引用スタイル

Niwakawa, M., Hashine, K., Yamaguchi, R., Fujii, H., Hamamoto, Y., Fukino, K., Tanigawa, T., & Sumiyoshi, Y. (2012). Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0). Investigational new drugs, 30(3), 1274-1275. https://doi.org/10.1007/s10637-011-9771-9

Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0). / Niwakawa, Masashi; Hashine, Katsuyoshi; Yamaguchi, Raizo その他.
In: Investigational new drugs, Vol. 30, No. 3, 06.2012, p. 1274-1275.

研究成果: Comment/debate › 査読

Niwakawa, M, Hashine, K, Yamaguchi, R, Fujii, H, Hamamoto, Y, Fukino, K, Tanigawa, T & Sumiyoshi, Y 2012, 'Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)', Investigational new drugs, vol. 30, no. 3, pp. 1274-1275. https://doi.org/10.1007/s10637-011-9771-9

@article{c24da30e907b47ca8b21e6de893e4250,

title = "Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)",

author = "Masashi Niwakawa and Katsuyoshi Hashine and Raizo Yamaguchi and Hirofumi Fujii and Yasuo Hamamoto and Koichi Fukino and Takahiko Tanigawa and Yoshiteru Sumiyoshi",

year = "2012",

month = jun,

doi = "10.1007/s10637-011-9771-9",

language = "English",

volume = "30",

pages = "1274--1275",

journal = "Investigational new drugs",

issn = "0167-6997",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Erratum

T2 - Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)

AU - Niwakawa, Masashi

AU - Hashine, Katsuyoshi

AU - Yamaguchi, Raizo

AU - Fujii, Hirofumi

AU - Hamamoto, Yasuo

AU - Fukino, Koichi

AU - Tanigawa, Takahiko

AU - Sumiyoshi, Yoshiteru

PY - 2012/6

Y1 - 2012/6

UR - https://www.scopus.com/pages/publications/84864335743

UR - https://www.scopus.com/pages/publications/84864335743#tab=citedBy

U2 - 10.1007/s10637-011-9771-9

DO - 10.1007/s10637-011-9771-9

M3 - Comment/debate

AN - SCOPUS:84864335743

SN - 0167-6997

VL - 30

SP - 1274

EP - 1275

JO - Investigational new drugs

JF - Investigational new drugs

IS - 3

ER -